Cite
HARVARD Citation
Kim, T. et al. (2020). Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing. Transfusion. 60 (10), pp. 2399-2407. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, T. et al. (2020). Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing. Transfusion. 60 (10), pp. 2399-2407. [Online].